Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
COG AAML1031: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD [Serum Biomarkers for the Prediction of GVHD in Children]
Hijiya, Nobuko
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
6/12/14
→
12/31/16
Funding
Children’s Hospital of Philadelphia
Hyundai Hope On Wheels
View all
View less